Finite cell line derived from a Autosomal recessive polycystic kidney disease patient's skin organ.


Finite cell line from a Autosomal recessive polycystic kidney disease patient's kidney.


Transformed cell line derived from portion of blood of a Epidermolysis Bullosa Simplex donor.


Transformed cell line derived from a Autosomal dominant generalized epidermolysis bullosa simplex, severe form patient's vertebrate blood.


Trisomy 22 Finite cell line derived from chorionic villus.


Carnitine-Acylcarnitine Translocase Deficiency Finite cell line derived from skin organ.


Finite cell line derived from entire skin of a Carnitine-acylcarnitine translocase deficiency donor.


Finite cell line from late embryo of a Fraser Syndrome donor.


Cryptophthalmos-Syndactyly Syndrome Finite cell line from skin of axilla.


Fraser syndrome Finite cell line from late embryo.


Finite cell line from skin of armpit of a donor with Fraser syndrome.


Aspartylglycosaminuria Transformed cell line derived from portion of blood.


Transformed cell line from portion of blood of a Aspartylglucosaminuria patient.


Salla Disease Finite cell line derived from skin organ.


Salla Disease Transformed cell line from portion of blood.


Finite cell line derived from a Free sialic acid storage disease patient's entire skin.


Free sialic acid storage disease Transformed cell line from vertebrate blood.


Generalized Arterial Calcification of Infancy 1 Transformed cell line derived from vertebrate blood.


Finite cell line derived from allantoic placenta of a patient with Generalized Arterial Calcification of Infancy 1.


Generalized arterial calcification of infancy Transformed cell line from portion of blood.


Generalized arterial calcification of infancy Finite cell line derived from eutherian placenta.


Transformed cell line derived from a Congenital Adrenal Hypoplasia donor's portion of blood.


Transformed cell line derived from portion of blood of a Adrenal hypoplasia congenita patient.


Bernard-Soulier Syndrome Transformed cell line derived from vertebrate blood.


Transformed cell line derived from vertebrate blood of a Bernard-Soulier syndrome patient.


Kallmann Syndrome Transformed cell line derived from portion of blood.


Kallmann syndrome Transformed cell line derived from portion of blood.


Transformed cell line derived from portion of blood of a patient with Greig Syndrome.


Transformed cell line derived from a Greig cephalopolysyndactyly syndrome donor's vertebrate blood.


Follicular Adenoma of the Thyroid Gland Finite cell line derived from thyroid.


Transformed cell line derived from a CNMX donor's portion of blood.


Transformed cell line from vertebrate blood of a X-linked centronuclear myopathy donor.


Sandhoff disease Transformed cell line derived from portion of blood.


Transformed cell line derived from vertebrate blood of a patient with Sandhoff disease.


Leber Hereditary Optic Atrophy Transformed cell line from portion of blood.


Transformed cell line from a Leber hereditary optic neuropathy donor's portion of blood.


Fryns Syndrome Finite cell line from late embryo.


Finite cell line derived from late embryo of a Fryns syndrome donor.


Finite cell line from skin organ of a De Sanctis-Cacchione Syndrome patient.


Transformed cell line from a De Sanctis-Cacchione Syndrome patient's vertebrate blood.


De Sanctis-Cacchione syndrome Finite cell line from skin organ.


De Sanctis-Cacchione syndrome Transformed cell line derived from portion of blood.


Atransferrinemia Transformed cell line derived from vertebrate blood.


Transformed cell line from a Congenital atransferrinemia donor's portion of blood.


Body of Uterus Leiomyoma Finite cell line derived from tunica muscularis (myometrium).


Marshall Syndrome Transformed cell line from vertebrate blood.


Marshall syndrome Transformed cell line derived from vertebrate blood.


Deficiency of Hydroxymethylglutaryl-CoA Lyase Transformed cell line derived from vertebrate blood.


Transformed cell line derived from a 3-hydroxy-3-methylglutaric aciduria patient's portion of blood.


Kennedy Disease Transformed cell line derived from vertebrate blood.


Transformed cell line derived from a Kennedy disease donor's portion of blood.


Finite cell line derived from a Niemann-Pick Disease, Type B patient's skin organ.


Transformed cell line derived from a Niemann-Pick Disease, Type B patient's vertebrate blood.


Finite cell line from a Chronic visceral acid sphingomyelinase deficiency patient's entire skin.


Transformed cell line derived from a Chronic visceral acid sphingomyelinase deficiency patient's vertebrate blood.


Finite cell line from vertebrate heart of a XX Male patient.


46,XX testicular difference of sex development Finite cell line derived from vertebrate heart.


Transformed cell line from portion of blood of a donor with Ellis-Van Creveld Syndrome.


Transformed cell line derived from portion of blood of a Ellis Van Creveld syndrome patient.


Oculocutaneous Albinism Type 1A Transformed cell line from vertebrate blood.


Transformed cell line derived from vertebrate blood of a patient with Oculocutaneous albinism type 1A.


Transformed cell line derived from a Albinism donor's portion of blood.


Oculocutaneous albinism Transformed cell line from portion of blood.


Finite cell line derived from late embryo of a Fetal Akinesia Deformation Sequence donor.


Finite cell line derived from a Fetal akinesia deformation sequence patient's late embryo.


Angelman Syndrome Transformed cell line derived from portion of blood.


Transformed cell line from a Angelman syndrome patient's vertebrate blood.


Transformed cell line from a WVS donor's vertebrate blood.


Transformed cell line derived from portion of blood of a Weaver syndrome patient.


Finite cell line from amniotic fluid of a patient with Multiple Carboxylase Deficiency.


Finite cell line derived from amniotic fluid of a donor with Holocarboxylase synthetase deficiency.


Transformed cell line derived from a Multiple Endocrine Adenomatosis Type IIB donor's portion of blood.


Transformed cell line derived from portion of blood of a donor with Multiple endocrine neoplasia type 2B.


Wermer Syndrome Transformed cell line from vertebrate blood.


Transformed cell line derived from a Multiple endocrine neoplasia type 1 patient's portion of blood.


Finite cell line from entire skin of a Harlequin Ichthyosis donor.


Harlequin Ichthyosis Finite cell line derived from umbilical vein.


Finite cell line from entire skin of a patient with Harlequin ichthyosis.


Finite cell line from umbilical vein of a Harlequin ichthyosis donor.


Transformed cell line from a Nevus of Ito patient's portion of blood.


Nevus of Ito Transformed cell line derived from portion of blood.


Transformed cell line derived from portion of blood of a Spondyloepimetaphyseal Dysplasia, Sponastrime Type donor.


SPONASTRIME dysplasia Transformed cell line from vertebrate blood.


myasthenia gravis Transformed cell line from portion of blood.


Transformed cell line from vertebrate blood of a Myasthenia gravis patient.


Spondyloperipheral Dysplasia Finite cell line from preputial skin.


Finite cell line from foreskin of penis of a patient with Spondyloperipheral dysplasia-short ulna syndrome.


Transformed cell line from portion of blood of a patient with Myoclonic Epilepsy Associated with Ragged-Red Fibers.


MERRF Transformed cell line derived from vertebrate blood.


Transformed cell line derived from vertebrate blood of a donor with 18q-Syndrome.


Monosomy 18q syndrome Transformed cell line derived from vertebrate blood.


Potocki-Shaffer Syndrome Transformed cell line from vertebrate blood.


Transformed cell line derived from vertebrate blood of a donor with Potocki-Shaffer syndrome.


Hyperimmunoglobulin D with Periodic Fever Syndrome Transformed cell line derived from vertebrate blood.


Transformed cell line derived from a Mevalonic aciduria patient's portion of blood.


Finite cell line from a Triple A Syndrome patient's muscle organ.


Triple A syndrome Finite cell line derived from muscle organ.


Glycogen Storage Disease Type IV Finite cell line from liver.


Glycogen storage disease due to glycogen branching enzyme deficiency Finite cell line derived from liver.


Transformed cell line from vertebrate blood of a patient with Proteus Syndrome.


Transformed cell line from a Proteus syndrome donor's portion of blood.


Finite cell line from skin organ of a Pyruvate dehydrogenase E1-alpha deficiency donor.


Finite cell line from a Incontinentia Pigmenti Syndrome patient's entire skin.


Incontinentia Pigmenti Syndrome Transformed cell line derived from portion of blood.


Finite cell line derived from a Incontinentia pigmenti donor's entire skin.


Transformed cell line from portion of blood of a donor with Incontinentia pigmenti.


Transformed cell line from portion of blood of a patient with Delta-Aminolevulinate Dehydratase Deficiency.


Transformed cell line from portion of blood of a patient with Porphyria due to ALA dehydratase deficiency.


Norrie Syndrome Transformed cell line derived from portion of blood.


Norrie disease Transformed cell line from vertebrate blood.


Hemophagocytic Syndrome Finite cell line from pulmo.


FHLH Transformed cell line derived from vertebrate blood.


Finite cell line from a Familial hemophagocytic lymphohistiocytosis donor's pulmo.


Familial hemophagocytic lymphohistiocytosis Transformed cell line from vertebrate blood.


Pettigrew Syndrome Transformed cell line derived from vertebrate blood.


Transformed cell line derived from vertebrate blood of a X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome donor.


Transformed cell line derived from vertebrate blood of a EAD donor.


Synaptic congenital myasthenic syndromes Transformed cell line derived from portion of blood.


CAVD Transformed cell line derived from portion of blood.


Transformed cell line derived from a Congenital bilateral absence of vas deferens patient's portion of blood.


Finite cell line from entire skin of a HPS1 donor.


Transformed cell line derived from a Hermansky-Pudlak Syndrome 1 patient's vertebrate blood.


Hermansky-Pudlak syndrome due to BLOC-3 deficiency Finite cell line derived from entire skin.


Hermansky-Pudlak syndrome due to BLOC-3 deficiency Transformed cell line from vertebrate blood.


Transformed cell line from portion of blood of a Rubinstein-Taybi Syndrome patient.


Transformed cell line from a Rubinstein-Taybi syndrome patient's portion of blood.


Transformed cell line from portion of blood of a Von Hippel Lindau Syndrome donor.


Transformed cell line from a Von Hippel-Lindau disease patient's vertebrate blood.


Finite cell line from skin organ of a patient with Multifunctional Enzyme Deficiency.


Finite cell line from skin organ of a donor with Bifunctional enzyme deficiency.


Neonatal Adrenoleukodystrophy Finite cell line from entire skin.


Finite cell line from a Neonatal Adrenoleukodystrophy patient's skin of arm.


Neonatal adrenoleukodystrophy Finite cell line derived from entire skin.


Neonatal adrenoleukodystrophy Finite cell line derived from skin of arm.


Transformed cell line from portion of blood of a donor with PNLIPD.


Transformed cell line derived from vertebrate blood of a Pancreatic triacylglycerol lipase deficiency donor.


Trichothiodystrophy Finite cell line derived from entire skin.


Trichothiodystrophy Transformed cell line derived from portion of blood.


Progressive Familial Intrahepatic Cholestasis Transformed cell line from vertebrate blood.


Progressive familial intrahepatic cholestasis Transformed cell line from portion of blood.


Transformed cell line derived from vertebrate blood of a Adrenal Gland Hyperplasia, Congenital, due to 3-Beta-Hydroxysteroid Dehydrogenase 2 Deficiency donor.


Transformed cell line derived from a Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency patient's portion of blood.


Transformed cell line derived from a Charcot-Marie-Tooth Disease Type 1B patient's vertebrate blood.


Charcot-Marie-Tooth disease type 1B Transformed cell line derived from vertebrate blood.


5,10-Methylenetetrahydrofolate Reductase Deficiency Finite cell line from skin organ.


5,10-Methylenetetrahydrofolate Reductase Deficiency Transformed cell line from vertebrate blood.


Homocystinuria due to methylene tetrahydrofolate reductase deficiency Finite cell line derived from entire skin.


Transformed cell line derived from portion of blood of a Homocystinuria due to methylene tetrahydrofolate reductase deficiency patient.


Finite cell line from a Leigh Disease donor's entire skin.


Leigh Syndrome Transformed cell line from vertebrate blood.


Finite cell line from entire skin of a Leigh syndrome patient.


Transformed cell line from vertebrate blood of a donor with Leigh syndrome.


Mental retardation, Aphasia, Shuffling Gait, and Adducted Thumbs Transformed cell line derived from vertebrate blood.


Transformed cell line from portion of blood of a MASA syndrome donor.


Transformed cell line from a Glycine Encephalopathy donor's vertebrate blood.


Transformed cell line derived from vertebrate blood of a Glycine encephalopathy donor.


Transformed cell line derived from a Williams syndrome donor's portion of blood.


Transformed cell line derived from vertebrate blood of a patient with Williams syndrome.


Transformed cell line derived from a Smith-Magenis Syndrome patient's portion of blood.


Transformed cell line from vertebrate blood of a Smith-Magenis syndrome patient.


DDS Finite cell line derived from tunica albuginea.


Finite cell line from a Denys-Drash syndrome patient's tunica albuginea.


Transformed cell line derived from vertebrate blood of a GCK-Associated Diabetes Mellitus patient.


Transformed cell line derived from a Hereditary Female Breast Carcinoma patient's vertebrate blood.


Transformed cell line derived from portion of blood of a Hereditary breast cancer patient.


Transformed cell line from a Glomus Tumor donor's vertebrate blood.


Transformed cell line from portion of blood of a donor with Glomus tumor.


Transformed cell line derived from a Holt-Oram Syndrome patient's vertebrate blood.


Transformed cell line derived from vertebrate blood of a donor with Holt-Oram syndrome.


Transformed cell line from vertebrate blood of a Generalized Epilepsy patient.


Transformed cell line from a Juvenile Myoclonic Epilepsy patient's portion of blood.


Transformed cell line from a Juvenile myoclonic epilepsy donor's portion of blood.


Early Onset Breast Ovarian Cancer Syndrome Transformed cell line derived from vertebrate blood.


Cancer cell line from a BRCA1 Syndrome donor's ascitic fluid.


Cancer cell line derived from axillary node of a BRCA1-Associated Hereditary Breast and Ovarian Cancer Syndrome donor.


Hereditary breast and/or ovarian cancer syndrome Transformed cell line from portion of blood.


Cancer cell line derived from a Hereditary breast and/or ovarian cancer syndrome donor's ascitic fluid.


Cancer cell line from a Hereditary breast and/or ovarian cancer syndrome donor's axillary node.


Cleft Palate Transformed cell line from vertebrate blood.


Cleft palate Transformed cell line from portion of blood.


Nemaline Myopathy 2 Transformed cell line derived from vertebrate blood.


Typical nemaline myopathy Transformed cell line from vertebrate blood.


Rachischisis Transformed cell line derived from vertebrate blood.


Neural tube closure defect Transformed cell line from portion of blood.


Transformed cell line from a DRPLA donor's vertebrate blood.


Transformed cell line from portion of blood of a donor with Dentatorubral pallidoluysian atrophy.


Transformed cell line derived from portion of blood of a patient with BRCA2-Associated Hereditary Breast and Ovarian Cancer Syndrome.


Cancer cell line from ascitic fluid of a BRCA2-Associated Hereditary Breast and Ovarian Cancer Syndrome donor.


Transformed cell line from a Morbid Obesity patient's vertebrate blood.


Finite cell line derived from a Fibroid Neoplasm donor's tunica muscularis (myometrium).


Transformed cell line from a HFE-Associated Hereditary Hemochromatosis donor's portion of blood.


Transformed cell line derived from portion of blood of a donor with Symptomatic form of HFE-related hemochromatosis.


Neuronal Intranuclear Inclusion Disease Transformed cell line from portion of blood.


Transformed cell line from vertebrate blood of a donor with Neuronal intranuclear inclusion disease.


Finite cell line derived from a Majewski Syndrome donor's amnios.


Polydactyly with Neonatal Chondrodystrophy Type II Finite cell line derived from chorionic villus.


Finite cell line from amnios of a donor with Short rib-polydactyly syndrome, Majewski type.


Finite cell line from chorionic villus of a donor with Short rib-polydactyly syndrome, Majewski type.


Transformed cell line derived from portion of blood of a donor with Cleft Lip/Palate-Ectodermal Dysplasia Syndrome.


Cleft lip/palate-ectodermal dysplasia syndrome Transformed cell line from portion of blood.


Transformed cell line from a Glucose-6-Phosphate Dehydrogenase Deficiency patient's vertebrate blood.


Class I glucose-6-phosphate dehydrogenase deficiency Transformed cell line from portion of blood.


Transformed cell line derived from a Hereditary Factor V Deficiency donor's portion of blood.


Congenital factor V deficiency Transformed cell line derived from vertebrate blood.


Transformed cell line from portion of blood of a Partial Epilepsy donor.


Finite cell line from a Familial Mediterranean Fever donor's skin organ.


Familial Mediterranean fever Finite cell line from skin organ.


Transformed cell line derived from a Spinocerebellar Ataxia donor's portion of blood.


Transformed cell line derived from vertebrate blood of a Hereditary ataxia patient.


Transformed cell line from vertebrate blood of a donor with PARK4.


Hereditary late-onset Parkinson disease Transformed cell line derived from portion of blood.


Transformed cell line derived from portion of blood of a Anhidrotic Ectodermal Dysplasia 1 donor.


Transformed cell line derived from vertebrate blood of a Hypohidrotic ectodermal dysplasia patient.


AF Transformed cell line from vertebrate blood.


Transformed cell line derived from a Familial atrial fibrillation patient's portion of blood.


Childhood Absence Epilepsy Transformed cell line derived from portion of blood.


Transformed cell line derived from portion of blood of a donor with Childhood absence epilepsy.


Transformed cell line from a Steele-Richardson-Olszewski Syndrome patient's portion of blood.


Progressive supranuclear palsy Transformed cell line derived from vertebrate blood.


DVT Transformed cell line derived from vertebrate blood.


Finite cell line derived from a Infantile Neuronal Ceroid Lipofuscinosis donor's entire skin.


Transformed cell line from a CLN1 donor's portion of blood.


Finite cell line derived from skin organ of a MDDGA4 patient.


Finite cell line derived from a Congenital muscular dystrophy, Fukuyama type donor's entire skin.


FSHD1 Transformed cell line from portion of blood.


Finite cell line derived from a FSHD1 patient's skeletal muscle tissue.


Transformed cell line from portion of blood of a Facioscapulohumeral dystrophy patient.


Facioscapulohumeral dystrophy Finite cell line from skeletal muscle tissue.


Transformed cell line derived from vertebrate blood of a patient with Sanjad-Sakati Syndrome.


Transformed cell line from vertebrate blood of a patient with Sanjad-Sakati syndrome.


BPS Finite cell line derived from entire skin.


Finite cell line from skin organ of a patient with Bartsocas-Papas syndrome.


Finite cell line from entire skin of a Glutaric Aciduria, Type 1 patient.


Finite cell line from skin organ of a donor with Glutaryl-CoA dehydrogenase deficiency.


Transformed cell line derived from portion of blood of a patient with Common AV Canal.


Transformed cell line derived from a Atrioventricular septal defect donor's vertebrate blood.


Cystinuria Transformed cell line from vertebrate blood.


Finite cell line from a Late Infantile Neuronal Ceroid Lipofuscinosis patient's entire skin.


Transformed cell line derived from a CLN2 patient's vertebrate blood.


Transformed cell line from a Infantile Refsum Disease patient's portion of blood.


Transformed cell line derived from vertebrate blood of a patient with Infantile Refsum disease.


Finite cell line from skin organ of a PBD1A patient.


Finite cell line derived from entire skin of a patient with Eagle-Barrett Syndrome.


Finite cell line from a Prune belly syndrome patient's entire skin.


Congenital Nephrotic Syndrome Finite cell line derived from zone of skin of anterolateral part of thorax.


Genetic nephrotic syndrome Finite cell line from zone of skin of anterior thoracic region.


Transformed cell line from skin organ of a Fanconi Anemia, Complementation Group D2 patient.


Fanconi Anemia, Complementation Group D2 Transformed cell line from portion of blood.


Transformed cell line derived from portion of blood of a Aspermia donor.


Chromosome Y microdeletion syndrome Transformed cell line from portion of blood.


Osteogenesis Imperfecta Type IV Finite cell line derived from skin organ.


Osteogenesis Imperfecta Type IV Transformed cell line derived from portion of blood.


Finite cell line derived from a Osteogenesis Imperfecta Type IV donor's skin of arm.


Finite cell line derived from entire skin of a Osteogenesis imperfecta type 4 donor.


Osteogenesis imperfecta type 4 Transformed cell line derived from vertebrate blood.


Finite cell line from skin of arm of a Osteogenesis imperfecta type 4 patient.


Finite cell line from a Alexander Disease patient's skin organ.


Alexander Disease Transformed cell line from portion of blood.


Alexander disease Finite cell line derived from skin organ.


Transformed cell line derived from a Alexander disease donor's vertebrate blood.


Transformed cell line from portion of blood of a Emery-Dreifuss Muscular Dystrophy 1, X-Linked donor.


X-linked Emery-Dreifuss muscular dystrophy Transformed cell line derived from portion of blood.


PBD7B Finite cell line derived from skin of arm.


Finite cell line from entire skin of a patient with Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD).


Finite cell line from skin organ of a donor with Short chain acyl-CoA dehydrogenase deficiency.


Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency Finite cell line derived from entire skin.


Finite cell line from skin organ of a donor with Very long chain acyl-CoA dehydrogenase deficiency.


Finite cell line derived from entire skin of a Isobutyryl-CoA Dehydrogenase Deficiency donor.


Finite cell line derived from a Isobutyryl-CoA dehydrogenase deficiency donor's skin organ.


2-Methylbutyryl-CoA Dehydrogenase Deficiency Finite cell line derived from entire skin.


Finite cell line derived from entire skin of a 2-methylbutyryl-CoA dehydrogenase deficiency patient.


Finite cell line from a Isovalericacidemia patient's entire skin.


Isovaleric acidemia Finite cell line derived from entire skin.


Finite cell line from a Mitochondrial Trifunctional Protein Deficiency patient's skin organ.


Finite cell line derived from a Mitochondrial trifunctional protein deficiency donor's skin organ.


Finite cell line derived from entire skin of a MPS9 patient.


Finite cell line derived from skin organ of a patient with Hyaluronidase deficiency.


Carnitine Palmitoyltransferase II Deficiency Finite cell line derived from entire skin.


Finite cell line derived from entire skin of a Carnitine palmitoyltransferase II deficiency patient.


Transformed cell line from a ARCI2 patient's vertebrate blood.


Transformed cell line derived from vertebrate blood of a Congenital ichthyosiform erythroderma patient.


X-Linked Agammaglobulinemia Transformed cell line from portion of blood.


X-linked agammaglobulinemia Transformed cell line derived from portion of blood.


Transformed cell line derived from portion of blood of a 47,XXX patient.


Finite cell line from vagina of a Trisomy X donor.


Trisomy X syndrome Transformed cell line from vertebrate blood.


Finite cell line from vagina of a donor with Trisomy X syndrome.


Transformed cell line from vertebrate blood of a Pantothenate Kinase-Associated Neurodegeneration donor.


Transformed cell line from portion of blood of a patient with Atypical pantothenate kinase-associated neurodegeneration.


Transformed cell line from vertebrate blood of a ADHD donor.


Transformed cell line derived from vertebrate blood of a HPS6 patient.


Transformed cell line from portion of blood of a Hermansky-Pudlak syndrome due to BLOC-2 deficiency patient.


Finite cell line from skin organ of a Cystinosis donor.


Finite cell line from skin organ of a Ocular cystinosis donor.


HPS2 Finite cell line derived from skin organ.


Hermansky-Pudlak syndrome due to AP-3 deficiency Finite cell line derived from skin organ.


Transformed cell line derived from vertebrate blood of a Frontonasal Dysplasia 1 patient.


Transformed cell line from a Frontorhiny patient's portion of blood.


Transformed cell line derived from vertebrate blood of a patient with Cleidocranial Dysostosis.


Cleidocranial dysplasia Transformed cell line derived from vertebrate blood.


Transformed cell line derived from vertebrate blood of a Type I Acrocephalosyndactyly patient.


Apert syndrome Transformed cell line from portion of blood.


Congenital Cerebellar Hypoplasia Transformed cell line from vertebrate blood.


Transformed cell line derived from portion of blood of a donor with Coenzyme Q10 deficiency.


Transformed cell line from a Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate patient's vertebrate blood.


Transformed cell line derived from a Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome donor's vertebrate blood.


Bulbar Palsy, Progressive, with Sensorineural Deafness Transformed cell line from portion of blood.


Transformed cell line from a RFVT3-related riboflavin transporter deficiency donor's vertebrate blood.


Dyggve-Melchior-Clausen Syndrome Transformed cell line from portion of blood.


Transformed cell line from vertebrate blood of a Dyggve-Melchior-Clausen disease donor.


Transformed cell line derived from a Straight-Chain Acyl-CoA Oxidase Deficiency donor's vertebrate blood.


Transformed cell line from vertebrate blood of a donor with Peroxisomal acyl-CoA oxidase deficiency.


Varadi-Papp Syndrome Transformed cell line derived from vertebrate blood.


Transformed cell line from portion of blood of a donor with Orofaciodigital syndrome type 6.


Holoprosencephaly-Polydactyly Syndrome Transformed cell line derived from portion of blood.


Transformed cell line from a Holoprosencephaly-postaxial polydactyly syndrome donor's vertebrate blood.


Transformed cell line derived from portion of blood of a Familial Fibrous Dysplasia of the Jaws patient.


Transformed cell line derived from vertebrate blood of a Cherubism donor.


Transformed cell line derived from vertebrate blood of a Pearson Syndrome patient.


Transformed cell line derived from vertebrate blood of a patient with Pearson syndrome.


Transformed cell line derived from vertebrate blood of a Möbius Syndrome patient.


Moebius syndrome Transformed cell line derived from vertebrate blood.


Hypochondroplasia Transformed cell line from vertebrate blood.


Transformed cell line from a Hypochondroplasia patient's portion of blood.


Transformed cell line derived from portion of blood of a Developmental Delay patient.


Hyperphosphatemic Familial Tumoral Calcinosis Transformed cell line from portion of blood.


Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome Transformed cell line from portion of blood.


Transformed cell line derived from a Hashimoto thyroiditis patient's portion of blood.


Transformed cell line derived from vertebrate blood of a patient with Vitiligo.


Transformed cell line from a Glycogen Storage Disease Type IX patient's vertebrate blood.


Glycogen Storage Disease Type IX Finite cell line from skin of arm.


Finite cell line derived from a Glycogen Storage Disease Type IX donor's hind limb stylopod skin.


Glycogen storage disease due to phosphorylase kinase deficiency Transformed cell line derived from vertebrate blood.


Finite cell line derived from a Glycogen storage disease due to phosphorylase kinase deficiency patient's skin of arm.


Finite cell line from a Glycogen storage disease due to phosphorylase kinase deficiency patient's hindlimb stylopod skin.


Transformed cell line from vertebrate blood of a Charcot-Marie-Tooth Disease Type 2D donor.


Transformed cell line derived from a Autosomal dominant Charcot-Marie-Tooth disease type 2D patient's portion of blood.


Transformed cell line from a Sotos' Syndrome donor's vertebrate blood.


Sotos syndrome Transformed cell line from portion of blood.


Leukoencephalopathy with Vanishing White Matter Transformed cell line from vertebrate blood.


Cree leukoencephalopathy Transformed cell line from portion of blood.


Transformed cell line from vertebrate blood of a patient with LGS.


Transformed cell line derived from a Lennox-Gastaut syndrome patient's portion of blood.


Finite cell line derived from a CDGIg donor's entire skin.


Finite cell line from a ALG12-CDG patient's entire skin.


Finite cell line from entire skin of a patient with Mucolipidosis Type IIIA.


Finite cell line from a Mucolipidosis type III alpha/beta donor's entire skin.


DFNB49 Transformed cell line from vertebrate blood.


Rare autosomal recessive non-syndromic sensorineural deafness type DFNB Transformed cell line from portion of blood.


DFNB28 Transformed cell line derived from portion of blood.


Langer Syndrome Transformed cell line derived from vertebrate blood.


Transformed cell line from a Langer mesomelic dysplasia donor's portion of blood.


Transformed cell line derived from a Fragile X Tremor/Ataxia Syndrome patient's portion of blood.


Fragile X-associated tremor/ataxia syndrome Transformed cell line derived from portion of blood.


Transformed cell line from a Vitamin D-resistant Rickets patient's portion of blood.


Transformed cell line derived from vertebrate blood of a X-linked hypophosphatemia patient.


Finite cell line from a Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency donor's skin organ.


Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency Finite cell line from entire skin.


Transformed cell line derived from a Methylmalonic Aciduria and Homocystinuria, cblC Type donor's portion of blood.


Transformed cell line from a Methylmalonic acidemia with homocystinuria, type cblC donor's portion of blood.


Finite cell line from a Molybdenum Cofactor Deficiency donor's skin organ.


Finite cell line from entire skin of a donor with Sulfite oxidase deficiency due to molybdenum cofactor deficiency.


Finite cell line from a Pseudothalidomide Syndrome patient's skin organ.


Roberts-SC Phocomelia Syndrome Transformed cell line from portion of blood.


Finite cell line from entire skin of a donor with Roberts syndrome.


Roberts syndrome Transformed cell line derived from portion of blood.


Finite cell line derived from umbilical vein of a Nephrotic Syndrome - NPHS1 Associated patient.


Finite cell line derived from umbilical vein of a patient with Congenital nephrotic syndrome, Finnish type.


Peters-Plus Syndrome Transformed cell line derived from portion of blood.


Peters plus syndrome Transformed cell line derived from vertebrate blood.


Transformed cell line from vertebrate blood of a donor with Spondyloepimetaphyseal Dysplasia with Joint Laxity Type 2.


Spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type Transformed cell line derived from portion of blood.


Transformed cell line derived from a Jackson-Weiss Syndrome patient's vertebrate blood.


Transformed cell line from a Jackson-Weiss syndrome donor's vertebrate blood.


Finite cell line derived from a IBMPFD1 donor's entire skin.


Finite cell line from a Adult-onset distal myopathy due to VCP mutation patient's skin organ.


Transformed cell line derived from portion of blood of a CDGIj patient.


Transformed cell line from a DPAGT1-CDG donor's portion of blood.


CDGIa Finite cell line derived from entire skin.


Finite cell line derived from entire skin of a PMM2-CDG patient.


Finite cell line derived from entire skin of a donor with CDGIe.


Finite cell line from skin organ of a patient with DPM1-CDG.


CDGId Finite cell line derived from skin organ.


ALG3-CDG Finite cell line from entire skin.


Finite cell line derived from a Congenital Disorder of Glycosylation Type Ic donor's skin organ.


Finite cell line from entire skin of a ALG6-CDG patient.


Finite cell line derived from entire skin of a patient with CDGIf.


Finite cell line derived from a MPDU1-CDG donor's skin organ.


Transformed cell line derived from a MRKH Syndrome donor's portion of blood.


Transformed cell line from portion of blood of a Mayer-Rokitansky-Küster-Hauser syndrome donor.


Transformed cell line derived from a Otopalatodigital Syndrome Type 1 donor's portion of blood.


Transformed cell line derived from a Otopalatodigital syndrome type 1 patient's portion of blood.


Transformed cell line from vertebrate blood of a donor with Mosaic Variegated Aneuploidy Syndrome 2.


Mosaic variegated aneuploidy syndrome Transformed cell line from vertebrate blood.


Finite cell line from skin organ of a donor with Cerebrooculofacioskeletal Syndrome.


COFS syndrome Finite cell line derived from skin organ.


Cancer cell line from ascitic fluid of a Signet Ring Cell Gastric Adenocarcinoma patient.


Signet Ring Cell Gastric Adenocarcinoma Cancer cell line from stomach.


Cancer cell line derived from pleural effusion of a Signet Ring Cell Adenocarcinoma of Stomach donor.


Cancer cell line derived from a Gastric Signet Ring Cell Adenocarcinoma patient's antrum of stomach.


Gastric Signet-Ring Cell Adenocarcinoma Cancer cell line from peri-gastric node.


Mantle cell lymphoma Transformed cell line from vertebrate blood.


Cancer cell line from vertebrate blood of a Classical Mantle Cell Lymphoma patient.


Cancer cell line derived from a Mantle Cell Lymphoma donor's medulla ossium.


Cancer cell line from a Mantle zone lymphoma patient's lymph node of neck.


Mantle cell lymphoma Transformed cell line from portion of blood.


Cancer cell line derived from a Mantle cell lymphoma donor's vertebrate blood.


Cancer cell line from medulla ossea of a donor with Mantle cell lymphoma.


Mantle cell lymphoma Cancer cell line derived from lymph node of neck.


Cancer cell line from ascitic fluid of a Stomach Carcinoma donor.


Cancer cell line from stomach of a patient with Cancer of the Stomach.


Cancer cell line from lymph node of a patient with Gastric Carcinoma.


Cancer cell line derived from pleural effusion of a donor with Stomach Carcinoma.


Cancer cell line from liver of a Carcinoma of the Stomach donor.


Cancer cell line from a Tubular Adenocarcinoma of Stomach patient's ascitic fluid.


Cancer cell line derived from stomach of a patient with Tubular adenocarcinoma.


Cancer cell line from a Tubular adenocarcinoma patient's lymph node.


Cancer cell line from liver of a Tubular Adenocarcinoma of the Stomach donor.


Myxoid Extraosseous Chondrosarcoma Cancer cell line derived from muscle organ.


Cancer cell line from a Extraskeletal myxoid chondrosarcoma donor's muscle organ.


Pleural Biphasic Mesothelioma Cancer cell line derived from pleural effusion.


Cancer cell line derived from a Pleural Biphasic Mesothelioma donor's wall of pleural sac.


Cancer cell line derived from portion of blood of a patient with Sezary disease.


Cancer cell line from a Sézary syndrome donor's vertebrate blood.


Cancer cell line from portion of blood of a patient with B-ALL with TCF3::HLF Rearrangement.


Cancer cell line derived from vertebrate blood of a donor with B-lymphoblastic leukemia/lymphoma with t(17;19).


Finite cell line derived from entire skin of a patient with epidermolysis bullosa.


Inherited epidermolysis bullosa Finite cell line from entire skin.


Cancer cell line derived from a Diffuse Large B-Cell Lymphoma Non-GC/ABC donor's vertebrate blood.


Diffuse Large B-Cell Lymphoma Activated B-Cell Type Cancer cell line from ascitic fluid.


Cancer cell line derived from a Non-GC/ABC DLBCL patient's lymph node.


Cancer cell line from a ABC DLBCL donor's pleural effusion.


Cancer cell line derived from medulla ossium of a patient with Diffuse Large B-Cell Lymphoma Non-GC/ABC.


Cancer cell line from a Activated B-Cell-Like Diffuse Large B-Cell Lymphoma patient's CSF.


Cancer cell line derived from a Meningioma, NOS donor's lobi frontales.


Cancer cell line derived from optic canal of a Meningioma donor.


Meningiomas Finite cell line from cluster of meninges.


Lung Giant Cell Carcinoma Cancer cell line derived from pulmo.


Cancer cell line from pleural effusion of a Giant Cell Carcinoma of the Lung donor.


Cancer cell line derived from mammary region of a Squamous Cell Breast Carcinoma, Acantholytic Variant patient.


Metastatic Breast Lobular Carcinoma Cancer cell line derived from pleural effusion.


NMC Cancer cell line from pulmo.


Cancer cell line from pleural effusion of a patient with NUT Midline Carcinoma.


NUT midline carcinoma Cancer cell line derived from pulmo.


NUT midline carcinoma Cancer cell line from pleural effusion.


Cancer cell line from lymph node of a donor with SCC of the Floor of Mouth.


Floor of Mouth Squamous Cell Carcinoma Cancer cell line derived from lymph node of neck.


SCC of the Floor of Mouth Cancer cell line from floor of the oval cavity.


Squamous Cell Carcinoma of Floor of Mouth Cancer cell line derived from Rivinus' gland.


Hemimegalencephaly Finite cell line derived from cortex of cerebral hemisphere.


Finite cell line derived from cortex of cerebral hemisphere of a Hemimegalencephaly donor.


Cancer cell line derived from a Adult T Lymphoblastic Lymphoma patient's pleural effusion.


Cancer cell line from a Hodgkin disease, NOS donor's portion of blood.


Hodgkin lymphoma Cancer cell line from lymph node.


Cancer cell line derived from pleural effusion of a patient with Hodgkin lymphoma.


Hodgkin's Disease Cancer cell line from medulla ossium.


Cancer cell line derived from vertebrate blood of a donor with Hodgkin lymphoma.


Cancer cell line derived from lymph node of a Hodgkin lymphoma donor.


Hodgkin lymphoma Cancer cell line derived from pleural effusion.


Cancer cell line from medulla ossea of a Hodgkin lymphoma donor.


Acoustic Schwannoma Transformed cell line from vestibular root of acoustic nerve.


Vestibular schwannoma Transformed cell line from vestibular root of acoustic nerve.


Pediatric Liver Cell Carcinoma Cancer cell line derived from liver.


Pediatric hepatocellular carcinoma Cancer cell line derived from liver.


CARCINOMA, HEPATOCELLULAR, MALIGNANT Cancer cell line derived from liver.


Cancer cell line from a Hepatocellular carcinoma donor's liver.


Finite cell line derived from a Mature Teratoma of the Stomach patient's peritoneum.


Extragonadal teratoma Finite cell line derived from peritoneum.


Cancer cell line derived from a Skin T-Cell Non-Hodgkin's Lymphoma patient's entire skin.


Cancer cell line from portion of blood of a donor with Cutaneous T-Cell Non-Hodgkin's Lymphoma.


Cancer cell line derived from skin organ of a donor with Primary cutaneous T-cell lymphoma.


Primary cutaneous T-cell lymphoma Cancer cell line derived from portion of blood.


Cancer cell line derived from a Uterine Carcinosarcoma patient's medulla ossium.


Malignant Mixed Mesodermal (Müllerian) Tumor of the Uterus Cancer cell line from uterus.


Carcinosarcoma of the corpus uteri Cancer cell line derived from medulla ossea.


Cancer cell line derived from a Carcinosarcoma of the corpus uteri patient's uterus.


Malignant Lymphomas of CNS Cancer cell line from brain.


Cancer cell line derived from a Primary central nervous system lymphoma patient's brain.


Cancer cell line derived from lymph node of neck of a Squamous Cell Carcinoma of Larynx donor.


Laryngeal Conventional Squamous Cell Carcinoma Cancer cell line derived from neck.


Cancer cell line from larynx of a Squamous Cell Carcinoma of the Larynx donor.


Cancer cell line from a Laryngeal Conventional Squamous Cell Carcinoma patient's supraglottis.


Laryngeal Squamous Cell Carcinoma Cancer cell line from glottis.


Cancer cell line from lymph node of neck of a donor with Squamous cell carcinoma of the larynx.


Cancer cell line from neck of a Squamous cell carcinoma of the larynx patient.


Squamous cell carcinoma of the larynx Cancer cell line from larynx.


Cancer cell line derived from a Squamous cell carcinoma of the larynx donor's supraglottic larynx.


Cancer cell line derived from a Squamous cell carcinoma of the larynx donor's glottis.


Mast Cell Leukemia Cancer cell line derived from vertebrate blood.


Mast cell leukemia Cancer cell line from vertebrate blood.


Cancer cell line derived from a Melanoma of the Vagina patient's vagina.


Cancer cell line from a Cervical Poorly Differentiated Adenosquamous Carcinoma donor's uterine cervix.


Cancer cell line from a Cervical Adenosquamous Carcinoma, Glassy Cell Variant donor's lymph node.


Glassy cell carcinoma of the cervix uteri Cancer cell line derived from canalis cervicis uteri.


Glassy cell carcinoma of the cervix uteri Cancer cell line derived from lymph node.


Cervical Melanoma Cancer cell line from cervical canal of uterus.


Lymphoma (Hodgkin's and Non-Hodgkin's) Cancer cell line derived from lymph node.


Cancer cell line derived from a LYMPHOMA, MALIGNANT patient's lymph node of neck.


Cancer cell line from lymph node of a patient with Histiocytic sarcoma.


Cancer cell line derived from a Histiocytic sarcoma patient's lymph node.


Finite cell line from a Chronic Lymphadenitis patient's lymph node.


Cancer cell line derived from entire skin of a donor with Dermatofibrosarcoma protuberans, NOS.


Cancer cell line derived from entire skin of a Dermatofibrosarcoma protuberans donor.


Germ Cell Teratoma of the Ovary Cancer cell line from female organism genitalia gonad.


Undefined cell line type derived from lymph node of a Hyperplastic donor.


Hyperplasia Undefined cell line type derived from mesenteric node.


Finite cell line derived from skin organ of a dermatitis donor.


Cancer cell line derived from lymph node of a patient with small lymphocytic lymphoma.


Cancer cell line from textus connectivus of a patient with Leiomyosarcoma.


Leiomyosarcoma Cancer cell line from gonad of female organism genitalia.


Leiomyosarcoma Cancer cell line derived from mammalian vulva.


Cancer cell line derived from a Leiomyosarcoma donor's textus connectivus.


Cancer cell line from entire skin of a Neurofibroma donor.


Cancer cell line from a Neurofibroma donor's skin organ.


Lung cancer, NOS Cancer cell line from pulmo.


Colorectal (Colon or Rectal) Adenocarcinoma Cancer cell line from large bowel.


Carcinoma of the Endocervix Cancer cell line derived from uterine cervix.


Cancer cell line derived from neck of uterus of a patient with Adenocarcinoma of the cervix uteri.


WHO Grade II Oligodendroglial Tumor Cancer cell line from brain.


Cancer cell line from left temporal lobe of a donor with WHO Grade II Oligodendroglial Tumor.


Oligodendroglioma Cancer cell line derived from brain.


Cancer cell line from left temporal lobe of a Oligodendroglioma patient.


Cancer cell line derived from osteogenic tissue of a donor with Tumor, NOS.


Cancer cell line from lesser pelvis of a Neoplastic Disease patient.


Other Neoplasm Cancer cell line derived from sacrum.


Giant cell tumor of bone, malignant Cancer cell line derived from osseous tissue.


OSTEOCLASTOMA, MALIGNANT Cancer cell line derived from vertebral column.


Cancer cell line derived from a Giant cell tumor of bone donor's osteogenic tissue.


Giant cell tumor of bone Cancer cell line derived from vertebral column.


Urethral Urothelial Carcinoma Cancer cell line derived from urethra.


Cancer cell line derived from a Urinary Bladder Transitional Cell Carcinoma donor's ureter.


Cancer cell line from ureter of a patient with Non-papillary transitional cell carcinoma of the bladder.


Fibrous Dysplasia Undefined cell line type from calcium tissue.


Fibrous dysplasia of bone Undefined cell line type derived from osteogenic tissue.


Histiocytoma Cancer cell line derived from portion of connective tissue.


Cancer cell line derived from a Osteoid Osteoma donor's osteogenic tissue.


Cancer cell line from entire skin of a patient with Paget's Disease.


Cancer cell line from pulmo of a donor with Epithelioid Sarcoma.


Cancer cell line from medulla ossium of a Epithelioid Sarcoma donor.


Epithelioid sarcoma Cancer cell line from pulmo.


Cancer cell line from a Epithelioid sarcoma donor's medulla ossea.


Cancer cell line derived from male prostate of a Malignant Schwannoma donor.


Cancer cell line derived from sciatic nerve of a Malignant Neurilemmoma donor.


Cancer cell line from hindlimb stylopodium of a patient with Malignant Neurilemmoma.


Cancer cell line from a MPNST, NOS donor's scapulae.


Cancer cell line derived from male prostate of a donor with Malignant peripheral nerve sheath tumor.


Cancer cell line from sciatic nerve of a donor with Malignant peripheral nerve sheath tumor.


Cancer cell line derived from a Malignant peripheral nerve sheath tumor patient's stylopod of hindlimb.


Malignant peripheral nerve sheath tumor Cancer cell line from scapulae.


Monophasic Sarcoma of the Synovium Cancer cell line derived from pleural effusion.


Cancer cell line derived from pulmo of a Synovial sarcoma patient.


Cancer cell line derived from a Synovial sarcoma donor's pleural effusion.


Synovial sarcoma Cancer cell line derived from iliac region.


Synovial sarcoma Cancer cell line derived from synovium.


Fanconi Anemia, Complementation Group B Transformed cell line derived from vertebrate blood.


Fanconi Anemia, Complementation Group D1 Transformed cell line derived from portion of blood.


Cancer cell line derived from gonad of female organism reproductive system of a Krukenberg Neoplasm patient.


Cancer cell line from antrum of Highmore of a Squamous Cell Carcinoma of Maxillary Sinus patient.


Cancer cell line from sinus maxilliaris of a Squamous cell carcinoma of the nasal cavity and paranasal sinuses donor.


Cancer cell line from a Recurrent Bladder Carcinoma donor's vesica urinaria.


actinic keratosis Finite cell line from skin organ.


Finite cell line from a Pre-Sacral Teratoma patient's coccygeal skeleton.


Finite cell line from a Sacrococcygeal teratoma patient's coccyx [vertebrae coccygeae I-IV].


Cancer cell line derived from lymph node of a Cutaneous T-cell lymphoma/Mycosis fungoides donor.


Cancer cell line from a Classic mycosis fungoides patient's lymph node.


Transformed cell line from portion of blood of a donor with Immunodeficiency with Hyper-IgM.


Transformed cell line derived from a X-linked hyper-IgM syndrome patient's portion of blood.


Wiskott Aldrich Syndrome Transformed cell line from portion of blood.


Transformed cell line from a Wiskott-Aldrich syndrome patient's vertebrate blood.


Transformed cell line derived from portion of blood of a Acquired Agammaglobulinemia donor.


Transformed cell line from vertebrate blood of a donor with Common variable immunodeficiency.


Transformed cell line derived from vertebrate blood of a patient with Immunoglobulin A Deficiency 1.


Transformed cell line derived from vertebrate blood of a patient with Recurrent infections associated with rare immunoglobulin isotypes deficiency.


Selective Antibody Deficiency with Normal Immunoglobulins Transformed cell line derived from vertebrate blood.


Specific antibody deficiency with normal immunoglobulin concentrations and normal numbers of B cells Transformed cell line from portion of blood.


Immunodeficiency 5 Transformed cell line derived from vertebrate blood.


Transformed cell line from portion of blood of a X-linked lymphoproliferative disease due to SAP deficiency patient.


Transformed cell line from a X-Linked Severe Combined Immunodeficiency patient's vertebrate blood.


Transformed cell line from a T-B+ severe combined immunodeficiency due to gamma chain deficiency patient's vertebrate blood.


Finite cell line derived from a Alkaptonuria donor's entire skin.


Alkaptonuria Finite cell line derived from entire skin.


Cancer cell line derived from a Intracranial Meningioma donor's brain.


Cancer cell line derived from lymph node of a Ovarian Squamous Cell Cancer patient.


Cancer cell line derived from cervical canal of uterus of a donor with Adenosquamous Cell Carcinoma of the Cervix.


Cancer cell line derived from a Adenosquamous Carcinoma patient's lymph node.


Cervical Squamous Cell Carcinoma, NOS Cancer cell line from neck of uterus.


Cancer cell line derived from left supraclavicular lymph node of a Cervical Squamous Cell Carcinoma, Not Otherwise Specified patient.


Cancer cell line from a precursor B-lymphoblastic leukemia donor's vertebrate blood.


Transformed cell line from portion of blood of a B-Cell Prolymphocytic Leukemia donor.


B-cell prolymphocytic leukemia Transformed cell line derived from vertebrate blood.


Cancer cell line derived from pleural effusion of a donor with Blastic Phase Chronic Myelocytic Leukemia.


Cancer cell line derived from a Blast Phase Chronic Myeloid Leukemia patient's medulla ossium.


Cancer cell line from pleural effusion of a Primary Mediastinal Clear Cell Lymphoma of B-Cell Type patient.


Cancer cell line from a Primary mediastinal large B-cell lymphoma donor's pleural effusion.


M2 Pediatric Acute Myelogenous Leukemia Cancer cell line derived from portion of blood.


Acute myeloblastic leukemia with maturation Cancer cell line from vertebrate blood.


Adult Acute Myeloblastic Leukemia with Minimal Differentiation Cancer cell line from medulla ossium.


Cancer cell line from a Acute myeloid leukemia with minimal differentiation patient's medulla ossium.


Cancer cell line derived from vertebrate blood of a Acute myelomonocytic leukemia donor.


Cancer cell line from cluster of meninges of a patient with Acute Myelomonocytic Leukemia.


Cancer cell line from a Acute myelomonocytic leukemia donor's vertebrate blood.


Cancer cell line derived from a Acute myelomonocytic leukemia patient's cluster of meninges.


Cancer cell line derived from a Ovarian Granulosa Cell Tumor donor's ovary stratum granulosum.


Cancer cell line derived from membrana granulosa of ovarian follicle of a Malignant granulosa cell tumor of the ovary donor.


Cancer cell line derived from vertebrate blood of a Natural Killer Cell Lymphoblastic Leukemia/Lymphoma donor.


Cancer cell line from pericardial fluid of a patient with Precursor NK Cell Lymphoblastic Leukemia/Lymphoma.


Prolymphocytic leukemia, T-cell type Cancer cell line derived from vertebrate blood.


Cancer cell line from a T-cell prolymphocytic leukemia donor's vertebrate blood.


B-Lymphoblastic Leukemia/Lymphoma with ETV6::RUNX1 Fusion Cancer cell line from portion of blood.


Cancer cell line from vertebrate blood of a patient with B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1).


Cancer cell line from liver of a Mixed Hepatocellular Cholangiocarcinoma donor.


Cancer cell line derived from liver of a Combined hepatocellular carcinoma and cholangiocarcinoma patient.


Pheochromocytoma Cancer cell line derived from medulla glandulae suprarenalis.


Cancer cell line from adrenal gland medulla of a patient with Sporadic pheochromocytoma/secreting paraganglioma.


Cancer cell line from ascitic fluid of a NCIT_C207229 patient.


NCIT_C207229 Cancer cell line from pancreas.


Cancer cell line derived from a NCIT_C207229 patient's liver.


Cancer cell line from a Inflammatory Carcinoma of Breast donor's mammary region.


Inflammatory Carcinoma of Breast Cancer cell line from pleural effusion.


Osseous Peripheral Neuroepithelioma Cancer cell line derived from pleural effusion.


Cancer cell line from a Peripheral primitive neuroectodermal tumor donor's pleural effusion.


Cancer cell line from a Peripheral primitive neuroectodermal tumor patient's content of orbital part of eye.


Cancer cell line from chest wall of a Peripheral primitive neuroectodermal tumor donor.


Undefined cell line type from medulla ossium of a Anemia patient.


Finite cell line derived from entire skin of a Ehlers-Danlos Syndrome, Kyphoscoliotic Type, 1 patient.


Kyphoscoliotic Ehlers-Danlos syndrome Finite cell line derived from entire skin.


Immunodeficiency with Hyper-IgM Type 2 Transformed cell line derived from vertebrate blood.


Transformed cell line from a Hyper-IgM syndrome type 2 donor's portion of blood.


Finite cell line derived from a Darier Disease patient's entire skin.


Darier disease Finite cell line from entire skin.


Finite cell line from pulmo of a IPF patient.


Finite cell line from pulmo of a donor with Idiopathic pulmonary fibrosis.


Cancer cell line derived from a Epithelioid hemangioendothelioma, NOS donor's liver.


Cancer cell line from a Epithelioid hemangioendothelioma donor's liver.


Cancer cell line derived from a Adenocarcinoma of Cecum donor's ascitic fluid.


Cancer cell line from lymph node of a donor with Adenocarcinoma of Cecum.


Cancer cell line derived from paries abdominalis of a Adenocarcinoma of the Cecum patient.


Adenocarcinoma of the Cecum Cancer cell line from peritoneum.


Cecal Adenocarcinoma Cancer cell line from cecum.


Adenocarcinoma of Cecum Cancer cell line derived from valva ileocaecalis (valva ilealis).


Cancer cell line from lymph node of a Cutaneous Nodular Melanoma patient.


Adult Acute Megakaryocytic Leukemia Cancer cell line from portion of blood.


Cancer cell line from a Adult Acute Megakaryocytic Leukemia (M7) patient's medulla ossium.


Mucinous Cystadenocarcinoma of Ovary Cancer cell line derived from reproductive system of female organism gonad.


Cancer cell line derived from ascitic fluid of a patient with Mucinous Cystadenocarcinoma of Ovary.


Cancer cell line from retromolar triangle of a Retromolar Trigone Squamous Cell Carcinoma donor.


Oropharyngeal Throat Squamous Cell Cancer Cancer cell line from lymph node.


Cancer cell line from lymph node of a Squamous cell carcinoma of the oropharynx patient.


Chronic Lymphocytic Leukemia Cancer cell line derived from portion of blood.


B-cell chronic lymphocytic leukemia Cancer cell line from portion of blood.


Cancer cell line from uterus of a patient with Sarcoma of Uterine Corpus.


Cancer cell line derived from uterus of a Sarcoma of the corpus uteri patient.


Cancer cell line derived from tunica mucosa (endometrium) of a Endometrial Adenosquamous Cancer donor.


Adenosquamous Carcinoma of Stomach Cancer cell line from lymph node.


Acute Myeloid Leukemia with t(6;11)(q27;q23); MLL-MLLT4 Cancer cell line derived from vertebrate blood.


Cancer cell line derived from a Acute Myeloid Leukemia with t(6;11)(q27;q23.3); KMT2A::MLLT4 donor's medulla ossium.


Transformed cell line from gonada of female organism genitalia of a Ovarian Serous Cystadenofibroma donor.


Benign Serous Cystadenoma of the Ovary Transformed cell line from female reproductive system gonad.


Cancer cell line from a Leukoplakia of Oral Mucosa patient's tongue.


Thyroid Gland Neuroendocrine Carcinoma Cancer cell line derived from thyroid.


Cancer cell line derived from thyroid of a donor with Medullary thyroid carcinoma.


M2 Adult Acute Granulocytic Leukemia with Maturation Cancer cell line from portion of blood.


Cancer cell line from vertebrate blood of a AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM donor.


Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) Cancer cell line from vertebrate blood.


Acute biphenotypic leukemia Cancer cell line from medulla ossium.


Mixed phenotype acute leukemia Cancer cell line derived from medulla ossea.


Pediatric Acute Lymphocytic Leukemia (ALL) Cancer cell line derived from vertebrate blood.


Cancer cell line from vertebrate blood of a Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 donor.


Transformed cell line from a Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 donor's vertebrate blood.


Cancer cell line derived from vertebrate blood of a patient with B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2).


Transformed cell line derived from a B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) donor's vertebrate blood.


B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) Cancer cell line derived from medulla ossea.


Cancer cell line derived from medulla ossea of a donor with APL.


Cancer cell line from a Acute promyelocytic leukemia donor's medulla ossium.


Bilateral Retinoblastoma Cancer cell line from eye socket.


Cancer cell line derived from CSF of a Bilateral Retinoblastoma patient.


Unilateral Retinoblastoma Cancer cell line from eye socket.


Bronchioloalveolar carcinoma Cancer cell line derived from pulmo.


Bronchioloalveolar carcinoma Cancer cell line derived from pleural effusion.


Cervix Uteri Small Cell Carcinoma Cancer cell line derived from neck of uterus.


Cancer cell line derived from cervix uteri of a patient with High-grade neuroendocrine carcinoma of the cervix uteri.


Cancer cell line from a Papillary Adenocarcinoma of Lung patient's lymph node.


Lung Papillary Adenocarcinoma Cancer cell line from pericardial fluid.


Lung Sarcomatoid Carcinoma Cancer cell line derived from pleural effusion.


Cancer cell line derived from pleural effusion of a patient with Pleural Sarcomatoid Mesothelioma.


Pleural Sarcomatoid Mesothelioma Cancer cell line derived from wall of pleural sac.


Malignant Mesothelioma of the Pleura Cancer cell line derived from pleural effusion.


Cancer cell line derived from lymph node of a donor with Lung Mucoepidermoid Cancer.


Carcinoma of the Adrenal Cortex Cancer cell line from glandula suprarenalis.


Cancer cell line from a Adrenocortical carcinoma patient's glandula suprarenalis.


Cancer cell line from a Prostate Small Cell NEC patient's lymph node of neck.


Cancer cell line derived from pulmo of a Pulmonary Carcinoid Tumor patient.


Cancer cell line from a EES donor's lesser pelvis.


Cancer cell line derived from pelvic region of a donor with Extraskeletal Ewing sarcoma.


Cancer cell line derived from testicle of a patient with Yolk Sac Tumor of the Testis.


Cancer cell line from gonad of female reproductive system of a patient with Yolk sac tumor.


Cancer cell line derived from testicle of a patient with Yolk sac tumor.


Cancer cell line derived from gonad of male reproductive system of a Embryonal Carcinoma of Testis patient.


Non-central nervous system-localized embryonal carcinoma Cancer cell line derived from gonad of male reproductive system.


Transformed cell line from a multiple system atrophy patient's vertebrate blood.


Multiple system atrophy Transformed cell line from vertebrate blood.


Transformed cell line derived from a Dementia with Lewy bodies patient's portion of blood.


Transformed cell line from portion of blood of a donor with Parkinson Disease 8, Autosomal Dominant.


Transformed cell line from a Arterial Ischemic Stroke donor's portion of blood.


Dissection of carotid artery Transformed cell line from portion of blood.


Seizure Disorder Transformed cell line derived from portion of blood.


Transformed cell line derived from vertebrate blood of a PARK2 patient.


Young-onset Parkinson disease Transformed cell line derived from portion of blood.


Transformed cell line from vertebrate blood of a Corticobasal Degeneration donor.


Transformed cell line from a Striatonigral degeneration donor's vertebrate blood.


Transformed cell line from portion of blood of a Racemose hemangioma donor.


Transformed cell line derived from vertebrate blood of a Subarachnoid hemorrhage donor.


Transformed cell line from a Intracerebral Hemorrhage donor's vertebrate blood.


Intracranial Aneurysm Transformed cell line from portion of blood.


Transformed cell line from a Pathologic AV Fistula patient's vertebrate blood.


Transformed cell line derived from a Progressive Muscular Atrophy donor's vertebrate blood.


Transformed cell line from a Progressive muscular atrophy patient's vertebrate blood.


Transformed cell line derived from portion of blood of a donor with Primary lateral sclerosis.


Primary lateral sclerosis Transformed cell line derived from vertebrate blood.


Transformed cell line derived from a Amyotrophic Lateral Sclerosis 14, With or Without Frontotemporal Dementia patient's portion of blood.


Transformed cell line derived from a ALS6 donor's vertebrate blood.


Transformed cell line from portion of blood of a Frontotemporal Dementia donor.


Transformed cell line from a Behavioral variant of frontotemporal dementia donor's vertebrate blood.


Transformed cell line from vertebrate blood of a MIBS patient.


Transformed cell line derived from a Pseudobulbar Palsy donor's portion of blood.


Progressive Bulbar Palsy Transformed cell line derived from portion of blood.


Transformed cell line from portion of blood of a patient with Bulbospinal muscular atrophy of adult.


Myxoid Malignant Fibrous Histiocytoma Cancer cell line from vertebrate hypodermis.


Cancer cell line derived from a Myxoid Malignant Fibrous Histiocytoma patient's knee region.


Cancer cell line derived from hypoderm of a patient with Myxofibrosarcoma.


Cancer cell line derived from a Myxofibrosarcoma patient's knee region.


Yolk Sac Tumor of Ovary Cancer cell line from gonad of female reproductive system.


Nasopharyngeal Throat Cancer Cancer cell line derived from rhinopharynx.


Nasopharyngeal carcinoma Cancer cell line derived from rhinopharynx.


ARMS Cancer cell line derived from pulmo.


Cancer cell line from medulla ossea of a alveolar rhabdomyosarcoma donor.


Cancer cell line from a Alveolar rhabdomyosarcoma donor's axillary node.


Cancer cell line derived from lower leg muscle of a donor with ARMS.


Cancer cell line derived from perineum muscle organ of a patient with Alveolar Rhabdomyosarcoma.


Cancer cell line from pulmo of a Alveolar rhabdomyosarcoma donor.


Alveolar rhabdomyosarcoma Cancer cell line from medulla ossea.


Alveolar rhabdomyosarcoma Cancer cell line from axillary node.


Cancer cell line from a Alveolar rhabdomyosarcoma donor's lower leg muscle.


Cancer cell line from a Alveolar rhabdomyosarcoma donor's muscle organ of perineum.


Cancer cell line derived from gullet of a donor with Adenocarcinoma of the esophagus.


Esophageal Adenocarcinoma Cancer cell line from esophagus distal third.


Cancer cell line derived from a Gastric Undifferentiated Carcinoma donor's pleural effusion.


Cancer cell line derived from pleural effusion of a Undifferentiated carcinoma of stomach donor.


Cancer cell line derived from vertebrate blood of a donor with HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia.


Cancer cell line from a Adult T-cell leukemia/lymphoma donor's portion of blood.


Cancer cell line derived from brain of a donor with Medulloblastoma, SHH-activated and TP53-wildtype.


Cystadenocarcinoma of Ovary Cancer cell line derived from gonada of female reproductive system.


Ovarian Cystadenocarcinoma Cancer cell line from ascitic fluid.


Head and Neck Basaloid Carcinoma Cancer cell line from buccal cavity.


Cancer cell line from right frontal lobe of a Neuroepithelioma donor.


Cancer cell line derived from retroperitoneum of a Primitive Neuroectodermal Tumor (PNET) donor.


neuroectodermal tumor Cancer cell line from os iliacum.


Cancer cell line derived from pancreatic insula of a Pancreatic Somatostatinoma donor.


Cancer cell line from a Somatostatinoma patient's pancreatic islet.


Grade 1 Astrocytoma Cancer cell line from brain.


Cancer cell line derived from a Pilocytic astrocytoma donor's brain.


Ovarian Leiomyosarcoma Cancer cell line from gonada of female organism genitalia.


Cancer cell line derived from a Squamous Cell Carcinoma of the Head and Neck donor's pleural effusion.


Cancer cell line from thyroid of a patient with Thyroid Gland Sarcoma.


Upper Gum SCC Cancer cell line derived from gums.


Transformed cell line from submandibular salivary gland of a donor with Salivary Gland Adenoid Cystic Carcinoma.


Adenoid Cystic Carcinoma of the Salivary Gland Cancer cell line derived from ductus sublingualis.


Finite cell line from entire skin of a donor with Pseudoachondroplasia.


Pseudoachondroplasia Finite cell line derived from entire skin.


Bladder Epidermoid Carcinoma Cancer cell line from vesica urinaria.


Cancer cell line from a Gastric Choriocarcinoma patient's omentum.


Cancer cell line from a Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm donor's ascitic fluid.


Cancer cell line derived from a Vulvar Leiomyosarcoma patient's female pudendum.


Cancer cell line derived from lymph node of a patient with Amelanotic Cutaneous Melanoma.


Cancer cell line derived from a Peripheral Neuroectodermal Tumor of Thoracopulmonary Region donor's content of orbital part of eye.


Cancer cell line derived from a Small Cell Tumor of Thoracopulmonary Region patient's chest wall.


Cancer cell line derived from uterus of a donor with Leiomyosarcoma of the Corpus Uteri.


Cancer cell line from uterus of a Leiomyosarcoma of the corpus uteri patient.


Cancer cell line derived from pons of Varolius of a DIPG patient.


Diffuse intrinsic pontine glioma Cancer cell line derived from pons of Varolius.


Anaplastic Breast Carcinoma Cancer cell line derived from mammary part of chest.


Cancer cell line derived from medulla ossea of a patient with Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1.


Transformed cell line derived from a Angiomyolipoma of Kidney patient's kidney.


Cancer cell line from humerus bone of a Primary Chondrosarcoma donor.


Cancer cell line from a Carcinoma of Vulva patient's lymph node.


Cancer cell line derived from a Vulvar carcinoma patient's lymph node.


Cancer cell line from pulmo of a donor with Biphasic Sarcoma of Synovium.


Cancer cell line from a Biphasic Sarcoma of the Synovium donor's inguinal region.


Cancer cell line derived from a Biphasic Sarcoma of Synovium patient's synovium.


Cancer cell line from medulla ossea of a donor with T-ALL.


Testicular Seminoma Cancer cell line from male gonad.


Cancer cell line from gonad of male genitalia of a Testicular seminomatous germ cell tumor patient.


Cancer cell line from inguinal lymph node of a Squamous Cell Carcinoma, Keratinizing donor.


Cancer cell line from lymph node of a NHL patient.


Cancer cell line from skin organ of a Basal Cell Epithelioma donor.


rhabdomyosarcoma Cancer cell line derived from portion of connective tissue.


Cancer cell line from portion of connective tissue of a donor with Rhabdomyosarcoma.


Cancer cell line derived from a Adenocarcinoma of Ampulla of Vater donor's ampulla biliaropancreatica.


Cancer cell line from a Carcinoma of the ampulla of Vater patient's ascitic fluid.


Carcinoma of the ampulla of Vater Cancer cell line derived from lymph node.


Cancer cell line from liver of a patient with Carcinoma of the ampulla of Vater.


Cancer cell line from a Carcinoma of the ampulla of Vater patient's biliaropancreatic ampulla.


Cancer cell line from lymph node of a donor with Undifferentiated Gallbladder Cancer.


Ampulla of Vater Adenosquamous Carcinoma Cancer cell line derived from ascitic fluid.


Ampulla of Vater Adenosquamous Carcinoma Cancer cell line derived from lymph node.


Cancer cell line derived from liver of a Ampulla of Vater Adenosquamous Carcinoma donor.


Clear cell carcinoma Cancer cell line derived from tunica mucosa (endometrium).


Cancer cell line from a Familial Thyroid Gland Medullary Carcinoma patient's thyroid.


Familial medullary thyroid carcinoma Cancer cell line derived from thyroid.


Cancer cell line from a Extrarenal Rhabdoid Tumor patient's liver.


Trichothiodystrophy 1, Photosensitive Finite cell line derived from skin organ.


Finite cell line from a TTD3 patient's skin organ.


TTD3 Transformed cell line from portion of blood.


Sacral Chordoma Cancer cell line from os sacrum [vertebrae sacrales I - V].


Cancer cell line from os sacrum [vertebrae sacrales I - V] of a patient with Chordoma.


Cancer cell line from a essential thrombocytosis patient's vertebrate blood.


Essential thrombocythemia Cancer cell line from vertebrate blood.


Squamous Cell Carcinoma of the Tonsil Cancer cell line derived from tonsillar bed.


Cancer cell line derived from a Carcinoma of the Renal Pelvis donor's pelvis of ureter.


Hereditary leiomyomatosis & RCC-associated renal cell carcinoma Cancer cell line derived from kidney.


Cancer cell line derived from a Hereditary leiomyomatosis and renal cell cancer donor's kidney.


Cancer cell line from portion of blood of a Splenic marginal zone B-cell lymphoma patient.


Cancer cell line from portion of blood of a Splenic marginal zone lymphoma donor.


Grade 1 Follicular Lymphoma Cancer cell line derived from portion of blood.


XPV Finite cell line from entire skin.


Transformed cell line from a XPV donor's portion of blood.


Finite cell line derived from skin of arm of a patient with XPV.


Finite cell line derived from a Xeroderma pigmentosum variant patient's entire skin.


Transformed cell line from vertebrate blood of a patient with Xeroderma pigmentosum variant.


Xeroderma pigmentosum variant Finite cell line derived from skin of arm.


Xeroderma Pigmentosum/Cockayne Syndrome Finite cell line from entire skin.


Xeroderma Pigmentosum-Cockayne Syndrome Complex Transformed cell line from skin organ.


Transformed cell line derived from vertebrate blood of a donor with XP-CS.


Finite cell line from a Xeroderma pigmentosum-Cockayne syndrome complex donor's skin organ.


Transformed cell line derived from skin organ of a Xeroderma pigmentosum-Cockayne syndrome complex donor.


Xeroderma pigmentosum-Cockayne syndrome complex Transformed cell line from portion of blood.


Finite cell line from a Xeroderma Pigmentosum Group G patient's skin organ.


Transformed cell line derived from portion of blood of a Xeroderma Pigmentosum Group G patient.


Finite cell line derived from entire skin of a patient with Xeroderma Pigmentosum, Complementation Group F.


Transformed cell line derived from entire skin of a Xeroderma Pigmentosum, Complementation Group F patient.


XP-B Finite cell line from entire skin.


Transformed cell line derived from vertebrate blood of a donor with Xeroderma Pigmentosum, Complementation Group B.


Cancer cell line from a Benign Neurilemmoma donor's vertebrate hypodermis.


Cancer cell line derived from arm of a donor with Benign Neurilemmoma.


Human papillomavirus type 18 transformed Human Papilloma Virus-Related Endocervical Adenocarcinoma Cancer cell line.


Macaca mulatta polyomavirus 1 Transformed cell line from a ENDOMETRIOSIS donor.


rhesus polyomavirus transformed LIG4 Syndrome cell line.


Simian virus 40 Transformed cell line from a LIG4 syndrome patient.


Cancer cell line from a patient with Human Papilloma Virus Related Cervical Squamous Cell Carcinoma, established by transfection with Human papillomavirus type 18.


Human papillomavirus type 68 transformed Cancer cell line from a Human Papillomavirus-Associated Cervical Squamous Cell Carcinoma patient.


Human papillomavirus type 16 transformed Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma Cancer cell line.


Human papillomavirus - 45 transformed Human Papillomavirus-Associated Cervical Squamous Cell Carcinoma Cancer cell line.


Human papillomavirus type 18 transformed Squamous cell carcinoma of the cervix uteri Cancer cell line.


Human papillomavirus type 68 transformed Cancer cell line from a Squamous cell carcinoma of the cervix uteri patient.


Human papillomavirus type 16 transformed Cancer cell line from a Squamous cell carcinoma of the cervix uteri donor.


Human papillomavirus - 45 transformed Cancer cell line from a Squamous cell carcinoma of the cervix uteri donor.


Cancer cell line from a EBV-Related Burkitt Lymphoma patient, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Cancer cell line from a Burkitt lymphoma patient, established by transfection with Epstein-Barr virus.


Polyomavirus maccacae transformed Finite cell line from a Cernunnos / XLF deficiency patient.


Rhesus macaque polyomavirus transformed Cernunnos-XLF deficiency Finite cell line.


N-(2-chloroethyl)-N'-(6-chloro-2-methoxyacridin-9-yl)propane-1,3-diamine dihydrochloride transformed Cancer cell line from a Fibrosarcoma, NOS patient.


N-(2-chloroethyl)-N'-(6-chloro-2-methoxyacridin-9-yl)propane-1,3-diamine dihydrochloride transformed Cancer cell line from a Fibrosarcoma patient.


Human herpesvirus 4 (Epstein-Barr virus) transformed AIDS-Related Burkitt's Lymphoma Cancer cell line.


Human herpesvirus type 4 transformed HIV-associated cancer Cancer cell line.


Rhesus macaque polyomavirus transformed DNA Ligase I Deficiency cell line.


Macaca mulatta polyomavirus 1 transformed Hypogammaglobulinemia cell line.


Human herpesvirus type 4 transformed HCV Infection cell line.


rhesus polyomavirus transformed cystic fibrosis cell line.


Human herpesvirus 4 (Epstein-Barr virus) transformed cystic fibrosis cell line.


Transformed cell line from a donor with Cystic fibrosis, established by transfection with Polyomavirus maccacae 1.


Epstein-Barr virus Transformed cell line from a Cystic fibrosis patient.


Cancer cell line from a Pleural Epithelioid Mesothelioma donor, established by transfection with asbestos.


Cancer cell line from a Pleural mesothelioma patient, established by transfection with asbestos.


Epstein Barr virus transformed Hutchinson-Gilford Disease cell line.


Epstein-Barr virus Transformed cell line from a Hutchinson-Gilford progeria syndrome donor.


Polyomavirus maccacae transformed Werner Syndrome cell line.


Human herpesvirus type 4 transformed adult progeria cell line.


Polyomavirus maccacae Transformed cell line from a Werner syndrome patient.


Epstein-Barr virus transformed Werner syndrome cell line.


Human herpesvirus 4 transformed Dyskeratosis Congenita cell line.


Human herpesvirus 4 transformed Dyskeratosis congenita cell line.


Transformed cell line from a patient with Familial Alzheimer's Disease, Type 3, established by transfection with Epstein-Barr virus EBV.


Human herpesvirus 4 transformed Early-onset autosomal dominant Alzheimer disease cell line.


Human herpesvirus 4 (Epstein-Barr virus) transformed Rothmund-Thompson Syndrome cell line.


Epstein-Barr virus transformed Rothmund-Thomson syndrome cell line.


Transformed cell line from a Ataxia Telangiectasia Syndrome patient, established by transfection with Polyomavirus maccacae.


Epstein-Barr virus EBV transformed Ataxia-Telangiectasia Syndrome cell line.


Macaca mulatta polyomavirus 1 transformed Ataxia-telangiectasia cell line.


Epstein-Barr virus EBV Transformed cell line from a Ataxia-telangiectasia patient.


Human herpesvirus type 4 transformed Alzheimer's disease, unspecified cell line.


Simian virus 40 Transformed cell line from a Cockayne Syndrome Type A patient.


Transformed cell line from a patient with Cockayne Syndrome Type A, established by transfection with Epstein Barr virus.


Rhesus macaque polyomavirus Transformed cell line from a Cockayne syndrome patient.


Transformed cell line from a patient with Cockayne syndrome, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Human herpesvirus 4 transformed MADA cell line.


Transformed cell line from a Mandibuloacral dysplasia with type A lipodystrophy patient, established by transfection with Epstein-Barr virus.


Transformed cell line from a patient with Parkinson Disease, established by transfection with Human herpesvirus 4.


Transformed cell line from a Kaposi Dermatosis donor, established by transfection with Human herpesvirus type 4.


Simian virus 40 transformed Finite cell line from a Xeroderma pigmentosum donor.


Transformed cell line from a donor with Xeroderma pigmentosum, established by transfection with Polyomavirus maccacae.


Transformed cell line from a Xeroderma pigmentosum donor, established by transfection with Epstein Barr virus.


Transformed cell line from a patient with Turner syndrome, established by transfection with Epstein Barr virus.


Human herpesvirus 4 transformed Turner syndrome cell line.


Epstein Barr virus Transformed cell line from a Familial Alzheimer Disease, Type 4 donor.


Human herpesvirus 4 transformed Diabetes Mellitus (Type I) cell line.


Human herpesvirus 4 Transformed cell line from a Trisomy 21 Syndrome patient.


Epstein Barr virus Transformed cell line from a Down syndrome donor.


Epstein-Barr virus Transformed cell line from a Gerstmann-Straussler-Scheinker Disease donor.


Epstein-Barr virus EBV transformed Gerstmann-Straussler-Scheinker syndrome cell line.


Epstein Barr virus Transformed cell line from a Pick Disease donor.


Epstein-Barr virus EBV Transformed cell line from a Frontotemporal dementia donor.


Epstein-Barr virus EBV transformed Transient Ischemic Attacks cell line.


Epstein-Barr virus EBV transformed Autism Spectrum Disorder cell line.


Human herpesvirus 4 transformed Pervasive Developmental Disorder cell line.


Human herpesvirus type 4 transformed Marfan syndrome cell line.


Transformed cell line from a Marfan syndrome donor, established by transfection with Epstein Barr virus.


Cancer cell line from a donor with Primary Effusion Lymphoma, established by transfection with Human herpesvirus type 4.


Cancer cell line from a donor with Primary Effusion Lymphoma, established by transfection with Human herpesvirus 8.


Epstein-Barr virus transformed Cancer cell line from a Primary effusion lymphoma donor.


Human herpesvirus 8 type P transformed Cancer cell line from a Primary effusion lymphoma patient.


Cancer cell line from a AIDS-Associated Immunoblastic Large Cell Lymphoma donor, established by transfection with Human herpesvirus 4.


Rhesus macaque polyomavirus transformed Fanconi Anemia, Complementation Group C cell line.


Transformed cell line from a Fanconi Anemia, Complementation Group C donor, established by transfection with Epstein-Barr virus.


Transformed cell line from a Fanconi anemia donor, established by transfection with Polyomavirus maccacae.


Human herpesvirus type 4 transformed Fanconi anemia cell line.


Epstein-Barr virus transformed acute myeloid leukemia Cancer cell line.


Transformed cell line from a donor with Acute myeloid leukemia, established by transfection with Epstein Barr virus.


Human herpesvirus 4 (Epstein-Barr virus) transformed Acute myeloid leukemia Cancer cell line.


Astatine-211 Alpha Radiation transformed Cancer cell line from a Acute myeloid leukemia donor.


Cancer cell line from a Burkitt lymphoma, unspecified site donor, established by transfection with Epstein Barr virus.


Cancer cell line from a patient with Hairy Cell Leukemia, established by transfection with Epstein Barr virus.


Human lymphotropic virus type II transformed Hairy cell leukemia Cancer cell line.


Human herpesvirus 4 (Epstein-Barr virus) transformed Cancer cell line from a Classic hairy cell leukemia donor.


Cancer cell line from a patient with Classic hairy cell leukemia, established by transfection with human T cell leukemia virus II HTLV-II.


Polyomavirus maccacae transformed Benign Hyperplasia of Prostate cell line.


Polyomavirus maccacae transformed Bare Lymphocyte Syndrome Type 1 cell line.


rhesus polyomavirus transformed Immunodeficiency by defective expression of MHC class I cell line.


Transformed cell line from a patient with Congenital Telangiectatic Erythema Syndrome, established by transfection with Simian virus 40.


Human herpesvirus 4 (Epstein-Barr virus) Transformed cell line from a Bloom syndrome donor.


N-Methyl-N'-nitro-N-nitrosoguanidine transformed Congenital Telangiectatic Erythema Syndrome cell line.


Macaca mulatta polyomavirus 1 transformed Bloom syndrome cell line.


Human herpesvirus type 4 Transformed cell line from a Bloom syndrome patient.


N-Methyl-N'-nitro-N-nitrosoguanidine transformed Bloom syndrome cell line.


Transformed cell line from a patient with Cancer of Prostate, established by transfection with Human papilloma virus type 18.


Human papilloma virus type 16 Transformed cell line from a Other Prostate Carcinoma patient.


Cancer cell line from a T-Cell Childhood Acute Lymphoblastic Leukemia patient, established by transfection with Human herpesvirus type 4.


N-(2-chloroethyl)-N'-(6-chloro-2-methoxyacridin-9-yl)propane-1,3-diamine dihydrochloride transformed Childhood T-Acute Lymphoblastic Leukemia Cancer cell line.


Cesium-137 Gamma Radiation transformed Cancer cell line from a Childhood T-Cell Acute Lymphoblastic Leukemia patient.


Cancer cell line from a Precursor T-cell acute lymphoblastic leukemia patient, established by transfection with Epstein Barr virus.


Cancer cell line from a Precursor T-cell acute lymphoblastic leukemia patient, established by transfection with N-(2-chloroethyl)-N'-(6-chloro-2-methoxyacridin-9-yl)propane-1,3-diamine dihydrochloride.


Cesium-137 Gamma Radiation transformed Cancer cell line from a Precursor T-cell acute lymphoblastic leukemia donor.


Human herpesvirus type 4 Transformed cell line from a Adult Acute Myeloid Leukemia donor.


Human herpesvirus 4 (Epstein-Barr virus) transformed Adult Acute Myeloid Leukemia Cancer cell line.


Astatine-211 Alpha Radiation transformed Cancer cell line from a Adult Acute Myelogenous Leukemia donor.


Epstein-Barr virus EBV transformed Cancer cell line from a Non-Hodgkin's B-Cell Lymphoma donor.


Human herpesvirus 4 transformed Cancer cell line from a B-cell non-Hodgkin lymphoma donor.


Human herpesvirus 4 (Epstein-Barr virus) transformed Cockayne Syndrome Type B cell line.


Human herpesvirus 4 Transformed cell line from a Noninsulin Dependent Diabetes donor.


Epstein Barr virus transformed Induced pluripotent stem cell from a Diabetes, Type 2 patient.


Epstein-Barr virus EBV transformed Cancer cell line from a Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma donor.


Human herpesvirus 4 transformed Cancer cell line from a Diffuse large B-cell lymphoma donor.


Epstein-Barr virus Transformed cell line from a Mono donor.


ethyl methanesulfonate Transformed cell line from a Infectious Mononucleosis patient.


Epstein-Barr virus transformed Fanconi Anemia, Complementation Group F cell line.


Polyomavirus maccacae transformed Fanconi Anemia, Complementation Group N cell line.


Transformed cell line from a donor with Fanconi Anemia, Complementation Group G, established by transfection with Rhesus macaque polyomavirus.


Transformed cell line from a Fanconi Anemia, Complementation Group G patient, established by transfection with Epstein-Barr virus.


Human hepatitis B virus transformed Adult Primary Hepatocellular Carcinoma Cancer cell line.


hepatitis B virus (HBV) transformed Adult hepatocellular carcinoma Cancer cell line.


Transformed cell line from a Argininosuccinate Synthetase Deficiency donor, established by transfection with Epstein-Barr virus EBV.


Transformed cell line from a patient with Citrullinemia type I, established by transfection with Epstein-Barr virus EBV.


Macaca mulatta polyomavirus 1 transformed Lesch-Nyhan Syndrome cell line.


Epstein-Barr virus Transformed cell line from a Lesch-Nyhan Syndrome patient.


Transformed cell line from a Lesch-Nyhan syndrome donor, established by transfection with Rhesus macaque polyomavirus.


Transformed cell line from a Lesch-Nyhan syndrome donor, established by transfection with Human herpesvirus type 4.


Epstein-Barr virus EBV transformed Hereditary Sensory and Autonomic Neuropathy Type III cell line.


Epstein-Barr virus transformed Familial dysautonomia cell line.


Transformed cell line from a asthma donor, established by transfection with Epstein-Barr virus EBV.


Polyomavirus maccacae 1 Transformed cell line from a Galactosemia patient.


Human herpesvirus type 4 Transformed cell line from a Galactosemia donor.


Polyomavirus maccacae transformed Galactosemia cell line.


Transformed cell line from a Galactosemia patient, established by transfection with Epstein-Barr virus.


Human herpesvirus 4 transformed Metachromatic Leukodystrophy cell line.


Transformed cell line from a Metachromatic leukodystrophy patient, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Epstein Barr virus Transformed cell line from a Mucopolysaccharidosis Type VI patient.


Transformed cell line from a donor with Mucopolysaccharidosis type 6, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Transformed cell line from a Fucosidosis donor, established by transfection with Human herpesvirus type 4.


Epstein-Barr virus transformed Fucosidosis cell line.


Human herpesvirus type 4 transformed MPS I H-S cell line.


Transformed cell line from a Hurler-Scheie syndrome patient, established by transfection with Human herpesvirus 4.


Transformed cell line from a Mucopolysaccharidosis Type IH donor, established by transfection with Epstein-Barr virus.


Epstein-Barr virus transformed Hurler syndrome cell line.


Epstein-Barr virus EBV Transformed cell line from a MODY1 patient.


Epstein-Barr virus transformed MODY cell line.


Human herpesvirus type 4 transformed MODY cell line.


Transformed cell line from a donor with Kinky Hair Syndrome, established by transfection with Epstein-Barr virus.


Human herpesvirus type 4 Transformed cell line from a Menkes disease donor.


Epstein-Barr virus EBV Transformed cell line from a Porphyria, Acute Intermittent donor.


Human herpesvirus 4 Transformed cell line from a Acute intermittent porphyria donor.


Transformed cell line from a patient with Maple Syrup Urine Disease, established by transfection with Epstein Barr virus.


Transformed cell line from a Maple syrup urine disease donor, established by transfection with Human herpesvirus type 4.


Human herpesvirus type 4 Transformed cell line from a Hyperlipoproteinemia, Type IIa donor.


Human herpesvirus 4 (Epstein-Barr virus) transformed Homozygous familial hypercholesterolemia cell line.


Epstein-Barr virus Transformed cell line from a Abetalipoproteinemia donor.


Transformed cell line from a Abetalipoproteinemia patient, established by transfection with Epstein-Barr virus EBV.


Transformed cell line from a Cystathioninuria donor, established by transfection with Epstein-Barr virus EBV.


Transformed cell line from a donor with Cystathioninuria, established by transfection with Epstein Barr virus.


Human herpesvirus 4 Transformed cell line from a Familial Combined Hyperlipidemia patient.


Epstein Barr virus transformed Familial chylomicronemia syndrome cell line.


Polyomavirus maccacae 1 transformed Glycogen Storage Disease Type II cell line.


Human herpesvirus 4 (Epstein-Barr virus) transformed Glycogen Storage Disease Type II cell line.


Rhesus macaque polyomavirus Transformed cell line from a Glycogen storage disease due to acid maltase deficiency patient.


Transformed cell line from a donor with Glycogen storage disease due to acid maltase deficiency, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Polyomavirus maccacae transformed Sporadic Retinoblastoma cell line.


Human herpesvirus 4 (Epstein-Barr virus) transformed Sporadic Retinoblastoma cell line.


rhesus polyomavirus Transformed cell line from a Retinoblastoma donor.


Human herpesvirus 4 (Epstein-Barr virus) Transformed cell line from a Retinoblastoma donor.


Human herpesvirus 4 Transformed cell line from a Schizophrenia patient.


Human herpesvirus 4 (Epstein-Barr virus) Transformed cell line from a Anorexia Nervosa donor.


Epstein-Barr virus EBV transformed Waldenström Macroglobulinemia cell line.


Epstein-Barr virus transformed Waldenström macroglobulinemia cell line.


Transformed cell line from a donor with Homocystinuria, established by transfection with Epstein-Barr virus EBV.


Transformed cell line from a Homocystinuria due to cystathionine beta-synthase deficiency patient, established by transfection with Human herpesvirus 4.


Epstein Barr virus transformed Gorlin syndrome cell line.


Human herpesvirus 4 (Epstein-Barr virus) transformed Gorlin syndrome cell line.


Epstein Barr virus Transformed cell line from a PKU patient.


Human herpesvirus 4 (Epstein-Barr virus) Transformed cell line from a Phenylketonuria patient.


Transformed cell line from a Inosine Triphosphatase Deficiency donor, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Human herpesvirus type 4 Transformed cell line from a ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement patient.


Epstein-Barr virus EBV transformed Neurofibromatosis cell line.


Epstein Barr virus Transformed cell line from a Neurofibromatosis type 1 patient.


Epstein-Barr virus Transformed cell line from a Tuberous Sclerosis 1 patient.


Human herpesvirus type 4 Transformed cell line from a Tuberous sclerosis complex donor.


Human herpesvirus type 4 transformed XP-E cell line.


Epstein-Barr virus EBV Transformed cell line from a ADA-SCID donor.


Epstein-Barr virus Transformed cell line from a Severe combined immunodeficiency due to adenosine deaminase deficiency patient.


Human herpesvirus 4 transformed Glucosylceramide Beta-Glucosidase Deficiency cell line.


Human herpesvirus type 4 transformed Gaucher disease cell line.


Epstein-Barr virus EBV transformed Mucopolysaccharidosis Type IIIA cell line.


Human herpesvirus 4 (Epstein-Barr virus) Transformed cell line from a Sanfilippo syndrome type A patient.


Epstein Barr virus transformed Wolfram Syndrome cell line.


Epstein Barr virus transformed Wolfram syndrome cell line.


Human herpesvirus type 4 transformed Sea-Blue Histiocyte Syndrome cell line.


Human herpesvirus type 4 Transformed cell line from a Sea-blue histiocytosis patient.


Transformed cell line from a Amyloidosis, Familial patient, established by transfection with Human herpesvirus type 4.


Human herpesvirus type 4 Transformed cell line from a Hereditary ATTR amyloidosis donor.


Epstein-Barr virus EBV transformed Hyperargininemia cell line.


Transformed cell line from a Argininemia patient, established by transfection with Epstein-Barr virus EBV.


Human herpesvirus 4 Transformed cell line from a Hereditary Persistence of Fetal Hemoglobin donor.


Human herpesvirus 4 Transformed cell line from a Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome donor.


Human herpesvirus 4 (Epstein-Barr virus) transformed HD cell line.


Human herpesvirus type 4 transformed Huntington disease cell line.


Transformed cell line from a donor with Autosomal Dominant Torsion Dystonia 1, established by transfection with Epstein-Barr virus.


Human herpesvirus 4 (Epstein-Barr virus) Transformed cell line from a Early-onset generalized limb-onset dystonia patient.


Human herpesvirus 4 (Epstein-Barr virus) transformed Thalassemia Major cell line.


Epstein-Barr virus Transformed cell line from a Beta-thalassemia major patient.


Human herpesvirus 4 Transformed cell line from a 21-Hydroxylase Deficieny patient.


Epstein Barr virus Transformed cell line from a Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency donor.


Epstein Barr virus transformed Dystonia Musculorum Deformans 2 cell line.


Epstein Barr virus transformed Primary dystonia, DYT2 type cell line.


Transformed cell line from a patient with Hereditary Coproporphyria, established by transfection with Epstein Barr virus.


Epstein-Barr virus EBV transformed Hereditary coproporphyria cell line.


Transformed cell line from a patient with Variegate Porphyria, established by transfection with Epstein-Barr virus EBV.


Transformed cell line from a Variegate porphyria donor, established by transfection with Human herpesvirus type 4.


Transformed cell line from a donor with Tay-Sachs Disease, established by transfection with Human herpesvirus type 4.


Transformed cell line from a Tay-Sachs disease patient, established by transfection with Human herpesvirus 4.


Human herpesvirus 4 (Epstein-Barr virus) transformed Chediak-Higashi Syndrome cell line.


Epstein Barr virus Transformed cell line from a Chédiak-Higashi syndrome patient.


Transformed cell line from a Mucolipidosis IV patient, established by transfection with Human herpesvirus type 4.


Human herpesvirus 4 (Epstein-Barr virus) Transformed cell line from a Mucolipidosis type IV patient.


Epstein Barr virus Transformed cell line from a Hemoglobin Lepore Syndrome patient.


Transformed cell line from a Hemoglobin Lepore-beta-thalassemia syndrome patient, established by transfection with Human herpesvirus type 4.


Transformed cell line from a Carnosinase Deficiency patient, established by transfection with Epstein-Barr virus.


Epstein Barr virus Transformed cell line from a Carnosinase deficiency patient.


Human herpesvirus 4 transformed Turcot Syndrome cell line.


Human herpesvirus type 4 transformed Turcot syndrome with polyposis cell line.


Epstein-Barr virus Transformed cell line from a Carbonic Anhydrase I Deficiency patient.


Human herpesvirus 4 transformed Mental Retardation cell line.


Epstein Barr virus transformed Cockayne syndrome cell line.


Epstein Barr virus Transformed cell line from a Argininosuccinate Lyase Deficiency patient.


Transformed cell line from a donor with Argininosuccinic aciduria, established by transfection with Epstein Barr virus.


Human herpesvirus 4 transformed Congenital Sucrase-Isomaltase Deficiency cell line.


Human herpesvirus type 4 Transformed cell line from a Congenital sucrase-isomaltase deficiency patient.


Transformed cell line from a donor with Type C1 Niemann-Pick Disease, established by transfection with Epstein-Barr virus.


Epstein-Barr virus transformed Niemann-Pick disease type C cell line.


Human herpesvirus 4 transformed PFKM Deficiency cell line.


Epstein Barr virus transformed Glycogen storage disease due to muscle phosphofructokinase deficiency cell line.


Human herpesvirus 4 (Epstein-Barr virus) transformed Fragile X Syndrome cell line.


Epstein-Barr virus Transformed cell line from a Fragile X syndrome donor.


Human herpesvirus 4 (Epstein-Barr virus) transformed FAP cell line.


Human herpesvirus 4 transformed Familial adenomatous polyposis cell line.


Transformed cell line from a donor with Multiple Sulfatase Deficiency Disease, established by transfection with Human herpesvirus type 4.


Human herpesvirus 4 Transformed cell line from a Multiple sulfatase deficiency patient.


Transformed cell line from a Coffin-Lowry Syndrome patient, established by transfection with Human herpesvirus 4.


Epstein-Barr virus Transformed cell line from a Coffin-Lowry syndrome donor.


Human herpesvirus 4 Transformed cell line from a Wilms Tumor of the Kidney patient.


Transformed cell line from a Nephroblastoma patient, established by transfection with Epstein-Barr virus EBV.


Transformed cell line from a Spinocerebellar Ataxia Type 7 patient, established by transfection with Epstein-Barr virus.


Epstein-Barr virus EBV Transformed cell line from a Spinocerebellar ataxia type 7 donor.


Human herpesvirus 4 transformed Alpha-1-Antitrypsin Deficiency cell line.


Human herpesvirus 4 (Epstein-Barr virus) Transformed cell line from a Alpha-1-antitrypsin deficiency patient.


Transformed cell line from a donor with retinoblastoma, established by transfection with Epstein-Barr virus EBV.


Epstein Barr virus transformed Steinert Disease cell line.


Transformed cell line from a donor with Steinert myotonic dystrophy, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Transformed cell line from a Duchenne donor, established by transfection with Epstein Barr virus.


Transformed cell line from a donor with Duchenne muscular dystrophy, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Human herpesvirus type 4 Transformed cell line from a Retinal Macular Dystrophy-1 donor.


Epstein-Barr virus EBV Transformed cell line from a North Carolina macular dystrophy donor.


Transformed cell line from a Retinitis Pigmentosa donor, established by transfection with Human herpesvirus type 4.


Transformed cell line from a Retinitis pigmentosa patient, established by transfection with Human herpesvirus 4.


Epstein Barr virus transformed Leber Congenital Amaurosis cell line.


Transformed cell line from a Leber congenital amaurosis patient, established by transfection with Human herpesvirus type 4.


Epstein Barr virus Transformed cell line from a Usher Syndrome Type 1 patient.


Epstein Barr virus Transformed cell line from a Usher syndrome type 1 patient.


Transformed cell line from a Hereditary Optic Atrophy donor, established by transfection with Human herpesvirus type 4.


Epstein Barr virus Transformed cell line from a Hereditary optic neuropathy patient.


Epstein-Barr virus Transformed cell line from a Refsum Disease patient.


Transformed cell line from a Refsum disease patient, established by transfection with Epstein-Barr virus EBV.


Transformed cell line from a donor with LGMD2A, established by transfection with Epstein Barr virus.


Human herpesvirus type 4 transformed Calpain-3-related limb-girdle muscular dystrophy R1 cell line.


Epstein-Barr virus EBV transformed Tuberous Sclerosis 2 cell line.


Epstein-Barr virus transformed Friedreich's Ataxia cell line.


Human herpesvirus 4 transformed Friedreich ataxia cell line.


Human herpesvirus type 4 Transformed cell line from a LEOPARD Syndrome donor.


Human herpesvirus 4 transformed Noonan syndrome with multiple lentigines cell line.


Epstein Barr virus transformed Pterygium of Conjunctiva and Cornea cell line.


Transformed cell line from a Familial pterygium of the conjunctiva patient, established by transfection with Human herpesvirus 4.


Epstein-Barr virus EBV transformed Prader-Willi Syndrome cell line.


Epstein-Barr virus Transformed cell line from a Prader-Willi syndrome patient.


Human herpesvirus 4 transformed Neuraminidase Deficiency with Beta-Galactosidase Deficiency cell line.


Human herpesvirus 4 transformed Galactosialidosis cell line.


Human herpesvirus 4 transformed Kearns-Sayre Syndrome cell line.


Human herpesvirus 4 (Epstein-Barr virus) transformed Kearns-Sayre syndrome cell line.


Transformed cell line from a Fabry Disease donor, established by transfection with Epstein-Barr virus EBV.


Human herpesvirus 4 (Epstein-Barr virus) transformed Fabry disease cell line.


Transformed cell line from a donor with PHP1A, established by transfection with Human herpesvirus 4 (Epstein-Barr virus).


Transformed cell line from a Albright hereditary osteodystrophy donor, established by transfection with Epstein Barr virus.